These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24800254)

  • 1. Is contrast medium osmolality a causal factor for contrast-induced nephropathy?
    Bucher AM; De Cecco CN; Schoepf UJ; Meinel FG; Krazinski AW; Spearman JV; McQuiston AD; Wang R; Bucher J; Vogl TJ; Katzberg RW
    Biomed Res Int; 2014; 2014():931413. PubMed ID: 24800254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-induced nephropathy.
    Persson PB
    Eur Radiol; 2005 Nov; 15 Suppl 4():D65-9. PubMed ID: 16479650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent issues in contrast-induced nephropathy.
    Kitajima K; Maeda T; Watanabe S; Sugimura K
    Int J Urol; 2011 Oct; 18(10):686-90. PubMed ID: 21834851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal haemodynamic alterations in contrast medium-induced nephropathy and the benefit of hydration.
    Persson PB; Patzak A
    Nephrol Dial Transplant; 2005 Feb; 20 Suppl 1():i2-5. PubMed ID: 15705945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous Contrast-Induced Nephropathy-The Rise and Fall of a Threatening Idea.
    Luk L; Steinman J; Newhouse JH
    Adv Chronic Kidney Dis; 2017 May; 24(3):169-175. PubMed ID: 28501080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical properties of radiographic contrast media, potential nephrotoxicity and prophylaxis.
    Hogstrom B; Ikei N
    Clin Exp Pharmacol Physiol; 2015 Dec; 42(12):1251-7. PubMed ID: 26743677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-induced nephropathy-choice of contrast agents to reduce renal risk.
    Katholi RE
    Am Heart Hosp J; 2009; 7(1):45-9. PubMed ID: 19742433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Clinical Factors on Risk of Contrast-Induced Nephrotoxicity From IV Iodinated Low-Osmolality Contrast Material in Patients With a Low Estimated Glomerular Filtration Rate.
    Ellis JH; Khalatbari S; Yosef M; Cohan RH; Davenport MS
    AJR Am J Roentgenol; 2019 Nov; 213(5):W188-W193. PubMed ID: 31268731
    [No Abstract]   [Full Text] [Related]  

  • 9. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
    Feldkamp T; Baumgart D; Elsner M; Herget-Rosenthal S; Pietruck F; Erbel R; Philipp T; Kribben A
    Clin Nephrol; 2006 Nov; 66(5):322-30. PubMed ID: 17140161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of contrast media.
    Solomon R; Briguori C; Bettmann M
    Kidney Int Suppl; 2006 Apr; (100):S39-45. PubMed ID: 16612400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proof of principle: hydration by low-osmolar mannitol-glucose solution alleviates undesirable renal effects of an iso-osmolar contrast medium in rats.
    Seeliger E; Ladwig M; Sargsyan L; Cantow K; Persson PB; Flemming B
    Invest Radiol; 2012 Apr; 47(4):240-6. PubMed ID: 22353855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function relationships of iodinated contrast media and risk of nephrotoxicity.
    Stratta P; Quaglia M; Airoldi A; Aime S
    Curr Med Chem; 2012; 19(5):736-43. PubMed ID: 22204333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
    Eng J; Wilson RF; Subramaniam RM; Zhang A; Suarez-Cuervo C; Turban S; Choi MJ; Sherrod C; Hutfless S; Iyoha EE; Bass EB
    Ann Intern Med; 2016 Mar; 164(6):417-24. PubMed ID: 26830055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality.
    Rudnick MR; Goldfarb S
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S28-33. PubMed ID: 14668707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients.
    Solomon R
    Kidney Int; 2005 Nov; 68(5):2256-63. PubMed ID: 16221227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical epidemiology of contrast-induced nephropathy.
    Parfrey P
    Cardiovasc Intervent Radiol; 2005; 28 Suppl 2():S3-11. PubMed ID: 16419277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts of contrast-induced nephropathy: a brief review.
    Chang CF; Lin CC
    J Chin Med Assoc; 2013 Dec; 76(12):673-81. PubMed ID: 24090599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-induced nephrotoxicity: clinical landscape.
    Katzberg RW; Haller C
    Kidney Int Suppl; 2006 Apr; (100):S3-7. PubMed ID: 16612398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
    Solomon R; Dumouchel W
    Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-induced nephropathy--prevention and risk reduction.
    Lameire NH
    Nephrol Dial Transplant; 2006 Jun; 21(6):i11-23. PubMed ID: 16723348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.